MML Investors Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.07M Buy
15,379
+7,033
+84% +$3.69M 0.02% 598
2025
Q1
$5.29M Buy
8,346
+813
+11% +$516K 0.02% 705
2024
Q4
$5.37M Buy
7,533
+2,218
+42% +$1.58M 0.02% 680
2024
Q3
$5.59M Buy
5,315
+648
+14% +$681K 0.02% 639
2024
Q2
$4.91M Sell
4,667
-736
-14% -$774K 0.02% 633
2024
Q1
$5.2M Sell
5,403
-176
-3% -$169K 0.02% 625
2023
Q4
$4.9M Buy
5,579
+1,387
+33% +$1.22M 0.02% 600
2023
Q3
$3.45M Buy
4,192
+1,688
+67% +$1.39M 0.02% 681
2023
Q2
$1.8M Buy
2,504
+349
+16% +$251K 0.01% 949
2023
Q1
$1.77M Sell
2,155
-341
-14% -$280K 0.01% 832
2022
Q4
$1.8M Sell
2,496
-119
-5% -$85.9K 0.01% 871
2022
Q3
$1.8M Sell
2,615
-70
-3% -$48.2K 0.01% 797
2022
Q2
$1.59M Buy
2,685
+286
+12% +$169K 0.01% 843
2022
Q1
$1.68M Sell
2,399
-1,215
-34% -$849K 0.01% 868
2021
Q4
$2.28M Buy
3,614
+574
+19% +$362K 0.02% 708
2021
Q3
$1.84M Sell
3,040
-5,169
-63% -$3.13M 0.01% 760
2021
Q2
$4.59M Buy
8,209
+70
+0.9% +$39.1K 0.04% 419
2021
Q1
$3.85M Buy
8,139
+4,664
+134% +$2.21M 0.04% 426
2020
Q4
$1.68M Sell
3,475
-155
-4% -$74.9K 0.02% 646
2020
Q3
$2.03M Buy
3,630
+157
+5% +$87.9K 0.03% 517
2020
Q2
$2.17M Buy
3,473
+1,210
+53% +$755K 0.03% 473
2020
Q1
$1.11M Sell
2,263
-1,716
-43% -$838K 0.02% 594
2019
Q4
$1.49M Sell
3,979
-60
-1% -$22.5K 0.02% 571
2019
Q3
$1.12M Sell
4,039
-1,394
-26% -$387K 0.02% 633
2019
Q2
$1.7M Sell
5,433
-120
-2% -$37.6K 0.02% 547
2019
Q1
$2.28M Sell
5,553
-1,641
-23% -$674K 0.04% 416
2018
Q4
$2.69M Sell
7,194
-420
-6% -$157K 0.05% 343
2018
Q3
$3.08M Buy
7,614
+1,560
+26% +$630K 0.05% 323
2018
Q2
$2.09M Sell
6,054
-21
-0.3% -$7.25K 0.05% 340
2018
Q1
$2.09M Buy
6,075
+1,344
+28% +$463K 0.04% 340
2017
Q4
$1.78M Buy
4,731
+774
+20% +$291K 0.03% 377
2017
Q3
$1.77M Buy
3,957
+123
+3% +$55K 0.04% 355
2017
Q2
$1.88M Buy
3,834
+1,136
+42% +$558K 0.04% 341
2017
Q1
$1.05M Buy
+2,698
New +$1.05M 0.02% 263